Presbyterian Hospital was a New York City hospital. It was founded in 1868 and began operations in 1872. It was originally located between East 70th Street and 71st Streets and Madison and Park Avenue.

During the past decade, Columbia Presbyterian Medical Center conducted 250 clinical trials. In the 10-year time frame, 250 clinical trials started and 105 clinical trials were completed, i.e. on average, 42% percent of trials that started reached the finish line to date. In the past 5 years, 123 clinical trials started and 67 clinical trials were completed. i.e. 54.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Columbia Presbyterian Medical Center" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 45 trials, followed by "Columbia University" with 38 trials sponsored, "Abbott Medical Devices" with 26 trials sponsored, "Edwards Lifesciences" with 19 trials sponsored and "Boston Scientific Corporation" with 19 trials sponsored. Other sponsors include 340 different institutions and companies that sponsored additional 212 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Columbia Presbyterian Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 13 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 13 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 12 trials as a collaborator and "Columbia University" with 8 trials as a collaborator. Other collaborators include 200 different institutions and companies that were collaborators in the rest 142 trials.

According to Clinical.Site data, the most researched conditions in "Columbia Presbyterian Medical Center" are "HIV Infections" (61 trials), "Coronary Artery Disease" (29 trials), "Heart Failure" (23 trials), "Tuberculosis" (11 trials) and "Stroke" (8 trials). Many other conditions were trialed in "Columbia Presbyterian Medical Center" in a lesser frequency.

Most popular intervention types in "Columbia Presbyterian Medical Center" are "Drug" (215 trials), "Device" (187 trials), "Procedure" (34 trials), "Biological" (31 trials) and "Other" (31 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (39 trials), "Zidovudine" (15 trials), "Didanosine" (12 trials), "Nevirapine" (11 trials) and "Lamivudine" (10 trials). Other intervention names were less common.

The vast majority of trials in "Columbia Presbyterian Medical Center" are 452 trials for "All" genders, 24 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are 154 active trials in "Columbia Presbyterian Medical Center". 4 are not yet recruiting, 91 are recruiting, 55 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 258 completed trials in Columbia Presbyterian Medical Center, 1 suspended trials, and 43 terminated clinical trials to date.

Out of the total trials that were conducted in Columbia Presbyterian Medical Center, 40 "Phase 1" clinical trials were conducted, 117 "Phase 2" clinical trials and 84 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 16 trials, and there were also 176 trials that are defined as “Not Applicable".